Research Article| Volume 33, ISSUE 5, P727-735, May 1992

Download started.


Lecithin:cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates.

Open AccessPublished:May 01, 1992DOI:
      This paper is only available as a PDF. To read, Please Download here.
      Plasma lipoprotein metabolism is influenced by several factors that may act by regulating the expression of proteins involved in lipoprotein metabolism, such as lecithin:cholesterol acyltransferase (LCAT). We determined the influence of several hormones and hypolipidemic drugs on hepatic LCAT gene expression and plasma LCAT activity. Liver LCAT mRNA levels were resistant to regulation by the hormones ethinylestradiol, L-thyroxine, hydrocortisone, or by the hypolipidemic drugs probucol, simvastatin, and nicotinic acid. In contrast, hepatic LCAT mRNA levels decreased to 67%, 64%, and 46% of the control levels after treatment with the fibric acid derivatives clofibrate, gemfibrozil, and fenofibrate, respectively. Fenofibrate lowered liver LCAT mRNA levels in a dose-dependent manner, which was paralleled by a decrease in plasma LCAT activity to 54% of the controls at a dose of 0.5% (w/w) in rat chow. The decrease in liver LCAT mRNA levels was maximal after 1 day, whereas the fall in plasma LCAT activity trailed by 2 days. Cessation of treatment with fenofibrate restored liver LCAT mRNA levels to control levels within 1 week. The transcription rate of the LCAT gene decreased by 25% in nuclei isolated from fenofibrate-treated rat liver, thereby indicating that hepatic LCAT gene expression is, at least partly, regulated at a transcriptional level. In contrast to the liver, brain and testis LCAT mRNA levels remained constant after treatment with fenofibrate, indicating that fibrates regulate LCAT gene expression in a tissue-selective manner.


        • Glomset J.A.
        The plasma lecithinxholesterol acyltransferase reaction.
        J. Lipid Res. 1968; 9: 155-167
        • Chen C.H.
        • Albers J.J.
        Activation of lecithin: cholesterol acyltransferase by apolipoprotein E-2, E-3, and A-IV isolated from human plasma.
        Biochim. Biophys. Acta. 1985; 826: 279-286
        • Steinmetz A.
        • Utermann G.
        Activation of lecithinxholesterol acyltransferase by human apolipoprotein A-IV.
        J. Biol. Chem. 1985; 260: 2258-2264
        • Fielding C.J.
        • Shore V.G.
        • Fielding P.E.
        A protein cofactor of lecithinxholesterol acyltransferase.
        Biochem. Biophys. Res. Commun. 1972; 46: 1493-1498
        • Jonas A.
        • Sweeny S.A.
        • Herbert P.N.
        Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithinxholesterol acyltransferase.
        J. Biol. Chem. 1984; 259: 6369-6375
        • Zorich N.
        • Jonas A.
        • Pownall H.
        Activation of lecithinxholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids.
        J. Biol. Chem. 1985; 260: 8831-8837
        • Soutar A.K.
        • Garner C.W.
        • Baker H.N.
        • Sparrow J.T.
        • Jackson R.L.
        • Gotto A.M.
        • Smith L.C.
        Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithinxholesterol acyltransferase.
        Biochemistry. 1975; 14: 3057-3063
        • Fielding C.J.
        • Fielding P.E.
        Cholesterol transport between cells and body fluids. Role of plasma lipoproteins and the plasma cholesterol esterification.
        Med. Clin. North Am. 1982; 66: 363-373
        • Eisenberg S.
        High density lipoprotein metabolism.
        J. Lipid Res. 1984; 25: 1017-1058
        • Teisberg P.
        • Gjone E.
        Genetic heterogeneity in familial lecithinxholesterol acyltransferase (LCAT) deficiency.
        Acta Med. Scand. 1981; 210: 1-2
        • Warden C.H.
        • Langner C.A.
        • Gordon J.I.
        • Taylor B.A.
        • McLean J.W.
        • Lusis A.J.
        Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithinxholesterol acyltransferase gene. Evidence for expression in brain and testis as well as liver.
        J. Biol. Chem. 1989; 264: 21573-21581
        • Rogne S.
        • Skretting G.
        • Larsen F.
        • Myklebost O.
        • Mevag B.
        • Carlson L.A.
        • Holmquist L.
        • Gjone E.
        • Prydz H.
        The isolation and characterization of a cDNA clone for human lecithinxholesterol acyltransferase and its use to analyse the genes in patients with LCAT deficiency and fish eye disease.
        Biochem. Biophys. Res. Commun. 1987; 148: 161-169
        • McLean J.
        • Wion K.
        • Drayna D.
        • Fielding C.
        • Lawn R.
        Human lecithinxholesterol acyltransferase gene: complete gene sequence and sites of expression.
        Nucleic Acids Res. 1986; 14: 9397-9406
        • McLean J.
        • Fielding C.
        • Drayna D.
        • Dieplinger H.
        • Baer B.
        • Kohr W.
        • Henzel W.
        • Lawn R.
        Cloning and expression of human lecithinxholesterol acyltransferase cDNA.
        Proc. Natl. Acad. Sci. USA. 1986; 83: 2335-2339
        • Tata F
        • Chaves M.E.
        • Markham A.F.
        • Scrace G.D.
        • Waterfield M.D.
        • Mclntyre N.
        • Williamson R.
        • Humphries S.E.
        The isolation and characterization of cDNA and genomic clones for human lecithinxholesterol acyltransferase.
        Biochim. Biophys. Acta. 1987; 910: 142-148
        • Meroni G.
        • Malgaretti N.
        • Magnaghi P.
        • Taramelli R.
        Nucleotide sequence of the cDNA for lecithin: cholesterol acyltransferase (LCAT) from the rat.
        Nucleic Acids Res. 1990; 18: 5308
        • Glomset J.A.
        • Wright J.L.
        Some properties of a cholesterol esterifying enzyme in human plasma.
        Biochim. Biophys. Acta. 1964; 89: 266-276
        • Chirgwin J.M.
        • Przybyla A.E.
        • MacDonald R.J.
        • Rutter W.J.
        Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
        Biochemistry. 1979; 18: 5294-5299
        • Staels B.
        • Auwerx J.
        • Chan L.
        • van Tol A.
        • Rosseneu M.
        • Verhoeven G.
        Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine.
        J. Lipid Res. 1989; 30: 1137-1145
        • Landschulz W.H.
        • Johnson P.F.
        • Adashi E.Y.
        • Graves B.J.
        • McKnight S.
        Isolation of a recombinant copy of the gene encoding C/EBP.
        Genes & Dev. 1988; 2: 786-800
        • Cleveland D.W.
        • Lopata M.A.
        • McDonald R.J.
        • Cowan M.J.
        • Rutter W.J.
        • Kirschner M.W.
        Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and gamma-actin genes using specific cloned cDNA probes.
        Cell. 1980; 20: 95-105
        • Gorski K.
        • Carneiro M.
        • Schibler U.
        Tissue-specific in vitro transcription from the mouse albumin promoter.
        Cell. 1986; 47: 767-776
        • Nevins J.R.
        Isolation and analysis of nuclear RNA.
        Methods Enzymol. 1987; 152: 234-241
        • Stahlberg D.
        • Angelin B.
        • Einarsson K.
        Effects of treatment with clofibrate, bezafibrate, and cipro- fibrate on the metabolism of cholesterol in rat liver microsomes.
        J. Lipid Res. 1989; 30: 953-958
        • Petit D.
        • Bonnefis M.T.
        • Rey C.
        • Infante R.
        Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
        Atherosclerosis. 1988; 74: 215-225
        • Dashti N.
        • Ontko J.A.
        Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
        Atherosclerosis. 1983; 49: 255-266
        • Laker M.E.
        • Mayes P.A.
        The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver.
        Biochem. Pharmacol. 1979; 28: 2813-2827
        • Thorp J.M.
        • Waring W.S.
        Modification of metabolism and distribution of lipids by ethylchloro-phenoxy-isobutyrate.
        Nature. 1962; 194: 948-949
        • Rodney G.
        • Black M.L.
        • Bird O.D.
        The common mode of action of three new classes of inhibitors of cholesterol biosynthesis.
        Biochem. Pharmacol. 1965; 14: 445-456
        • Sgoutas D.S.
        Fatty acid specificity of plasma phos-phatidycholinexholesterol acyltransferase.
        Biochemistry. 1972; 11: 293-296
        • Vessby B.
        • Lithell H.
        • Hellsing K.
        • Ostlund-Lindqvist A-M.
        • Gustafsson I-B.
        • Boberg J.
        • Ledermann H.
        Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.
        Atherosclerosis. 1980; 37: 257-269
        • Berry C
        • Moxham A.
        • Smith E.
        • Kellie A.E.
        • Nabarro J.D.N.
        The effects of atromid on the metabolism of adrenal steroids and on plasma lipid fractions.
        J. Atheroscler. Res. 1963; 3: 380-395
        • Jurand J.
        • Oliver M.J.
        The effects of ethyl chlo-rophenoxyisobutyrate on serum cholesteryl, triglyceride and phospholipid fatty acids.
        J. Atheroscler. Res. 1963; 3: 547-553
        • Vessby B.
        • Lithell H.
        • Gustafsson I-B.
        • Boberg J.
        Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate, but not by niceritrol.
        Atherosclerosis. 1980; 35: 51-65
        • Hagopian M.
        • Robinson R.W.
        The effect of chlorophenoxyisobutyrate on plasma composition of cholesteryl esters and on levels of neutral lipids.
        J. Atheroscler. Res. 1968; 8: 21-27
        • DAlessandro A.
        • Zucconi A.
        • Bellini F.
        • Boncinelli L.
        • Chiostri R.
        Lecithinxholesterol acyltransferase activity in hypercholesterolemic subjects and in hypercholes-terolemic subjects treated with clofibrate.
        Lipids. 1975; 10: 804-807
        • Wallentin L.
        Lecithinxholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjects.
        Atherosclerosis. 1978; 31: 41-52
        • Heller F.R.
        • Desager J.P.
        • Harvengt C.
        Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
        Int. J. Clin. Pharmacol. Ther. Toxicol. 1988; 26: 138-142
        • Weisweiler P.
        Simvastatin and bezafibrate: effects on serum lipoproteins and lecithinxholesterol acyltransferase activity in familial hypercholesterolemia.
        Eur. J. Clin. Pharmacol. 1988; 35: 579-583
        • Heller R
        • Harvengt C.
        Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
        Eur. J. Clin. Pharmacol. 1983; 25: 57-63
        • Weisweiler P.
        Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithinxholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
        Metabolism. 1989; 38: 271-275
        • Heller F.R.
        • Desager J.P.
        • Harvengt C.
        Plasma lipid concentrations and lecithinxholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
        Metabolism. 1981; 30: 67-71
        • Svoboda D.J.
        • Azarnoff D.L.
        Response of hepatic microbodies to a hypolipidemic agent, ethylchloro-phenoxyisobutyrate (CPIB).
        J. Cell Biol. 1966; 30: 442-450
        • Reddy J.K.
        • Azarnoff D.L.
        • Hignite C.E.
        Hypolipidaemic hepatic peroxisome proliferators form a new class of chemical carcinogens.
        Nature. 1980; 283: 397-398
        • Reddy J.K.
        • Warren J.R.
        • Reddy M.K.
        • Lalwani M.D.
        Hepatic and renal effects of peroxisome proliferators: biological implications.
        Ann. NY Acad. Sci. 1982; 386: 81-110
        • Wolfe B.M.
        • Kane J.P.
        • Havel R.J.
        • Brewster H.P.
        Mechanism of the hypolipidemic effect of clofibrate in postabsorptive men.
        J. Clin. Invest. 1973; 52: 2146-2159
        • Thomassen M.S.
        • Helgerud P.
        • Norum K.R.
        Chain-shortening of erucic acid and microperoxisomal β-oxidation in rat small intestine.
        Biochem. J. 1985; 225: 301-306
        • Lock E.A.
        • Mitchell A.M.
        • Elcombe C.R.
        Biochemical mechanisms of induction of hepatic peroxisome proliferation.
        Annu. Rev. Pharmacol. Toxicol. 1989; 29: 145-163
        • Isseman I.
        • Green S.
        Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.
        Nature. 1990; 347: 645-650
        • Cannon J.R.
        • Eacho P.I.
        Interaction of LY171883 and other peroxisome proliferators with fatty-acid binding protein isolated from rat liver.
        Biochem. J. 1991; 280: 387-391
        • Staels B.
        • van Tol A.
        • Verhoeven G.
        • Auwerx J.
        Apolipoprotein A-IV mRNA abundance is regulated in a tissue-specific manner.
        Endocrinology. 1990; 126: 2153-2163
        • Ridgway N.D.
        • Dolphin P.J.
        Serum activity and hepatic secretion of lecithinxholesterol acyltransferase in experimental hypothyroidism and hypercholesterolemia.
        J. Lipid Res. 1985; 26: 1300-1313
        • Rosenqvist V.
        • Mahler R.
        • Carlsson L.A.
        Lipid transport in the hypothyroid rat as reflected by the serum concentrations of free fatty acids, lipoproteins, lecithinxholesterol acyltransferase and lipoprotein lipase activity in adipose tissue.
        J. Endocrinol. Invest. 1981; 4: 75-80
        • Doi Y.
        • Nishida T.
        Microheterogeneity and physical properties of human lecithinxholesterol acyltransferase.
        J. Biol. Chem. 1983; 258: 5840-5846